Example: Heart Attack

Search clinical trials for: Tolbutamide

Total 30 results

NCT01185548

Terminated

A Drug Interaction Study of Tasisulam in Patients With Advanced Cancer or Lymphoma

Conditions: Lymphoma; Advanced Cancer
NCT03291288

Active, not recruiting

Effect of Pexidartinib on the Way the Body Processes CYP3A4 and CYP2C9 Substrates (Pharmacokinetics)

Conditions: Drug Interaction Potential
NCT02515526

Completed

Effect of Acute Ethanol Consumption on The Activity of Major Cytochrome P450 Enzymes, NAT2 and P-glycoprotein

Conditions: AOD Effects and Consequences
NCT02211079

Completed

A Study to Assess Effect of JNJ-54861911 on Pharmacokinetics of Cocktail Representatives for Cytochrome P450 (CYP) 3A4, CYP2B6, CYP2C9, and CYP1A2 Substrates

Conditions: Healthy
NCT03716427

Completed

Drug Interaction Study of CT1812 in Healthy Volunteers

Conditions: Healthy Volunteers
NCT02182401

Terminated

Multiple Doses of BI 207127 NA, BI 201335 NA Followed by the Combination of BI 207127 NA and BI 201335 NA in Healthy Male Volunteers

Conditions: Healthy
NCT00930306

Completed

AZD2066 Cocktail Study

Conditions: Chronic Pain
NCT01525628

Completed

Drug Drug Interaction Study Between BI 201335 and BI 207127 in Chronic Hepatitis C Infected Patients

Conditions: Hepatitis C, Chronic
NCT01061112

Completed

Effects of Genotype on CYP2C9 Drug Interactions

Conditions: Healthy
NCT00185003

Completed

Blockade of Vascular Potassium Channels During Human Endotoxemia

Conditions: Endotoxemia
NCT01147887

Completed

A Pharmacokinetic and Drug Interaction Study of JNJ-26489112 in Healthy Volunteers

Conditions: Healthy
NCT03457597

Completed

Study in Healthy Subjects to Determine the Effect of Relacorilant on Exposure to Probe Substrates for Cytochrome P450s

Conditions: Healthy
NCT02473627

Completed

A PHASE 1, OPEN-LABEL, CROSS-OVER, FIXED SEQUENCE STUDY TO EVALUATE THE EFFECT OF MULTIPLE DOSES OF DS-1971A ON THE SINGLE DOSE PHARMACOKINETICS OF PROBE SUBSTRATES FOR CYP2B6, CYP2C8, CYP2C9, CYP2C19 AND CYP3A4 ENZYMES IN HEALTHY MALE AND FEMALE SUBJECTS

Conditions: Healthy
NCT03103568

Completed

A Study to Investigate the Potential Influence of Nitisinone on the Metabolism and the Transport of Other Drugs in Healthy Volunteers

Conditions: Drug Drug Interaction
NCT01237522

Completed

A Pharmacokinetic Evaluation of Metformin in Relation to the Polymorphism A270S in Healthy Caucasian Volunteers

Conditions: Metformin; Organic Cation Transporter 2; Polymorphism,Single Nucleotide
NCT04525235

Not yet recruiting

Phenotyping of High Dose Rifampicin

Conditions: Tuberculosis
NCT03948243

Active, not recruiting

Licorice Botanical Dietary Supplements - Metabolism and Safety in Women

Conditions: Food-drug Interaction
NCT01260844

Withdrawn

Open Label, Single Dose, Non-randomized Study to Assess the Drug to Drug Interaction of Briakinumab on CYP Substrates.

Conditions: Moderate to Severe Plaque Psoriasis
NCT02291666

Completed

Evaluation of CYP450 Activities in Diabetic Patients vs. Non-diabetic Subjects

Conditions: Type 2 Diabetes
NCT01218620

Completed

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced Solid Tumors

Conditions: Adult Solid Neoplasm
NCT00741468

Completed

Open-Label, Multiple-Dose, Non-Randomized Study to Assess Drug-Drug Interactions of Proellex® in Female Subjects

Conditions: Drug Interactions
NCT03723395

Completed

A Drug-Drug Interaction Study in Healthy Volunteers of the Effects of Tucatinib

Conditions: Drug-drug Interaction
NCT02819102

Completed

An Open-label Drug-Drug Interaction Study to Evaluate the Effect of BCX7353 on Cytochrome P450 Enzyme Activity Using Probe Substrates

Conditions: Hereditary Angioedema
NCT01188525

Completed

Pharmacokinetic Study to Characterize Individual Metabolic Profile

Conditions: Healthy Volunteers
NCT01068860

Completed

To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes Therapies

Conditions: Type 2 Diabetes Mellitus; Impaired Glucose Tolerance